Hakutulokset - Richard Elion

  • Näytetään 1 - 19 yhteensä 19 tuloksesta
Tarkenna hakua
  1. 1
    Weight Loss as a Predictor of Survival and Disease Progression in HIV Infection

    Weight Loss as a Predictor of Survival and Disease Progression in HIV Infection Tekijä David A. Wheeler, Cynthia L. Gibert, Cynthia A. Launer, Norma Muurahainen, Richard Elion, Donald I. Abrams, Glenn E. Bartsch

    Julkaistu 1998
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study

    Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study Tekijä Frank J. Palella, Stephen J. Gange, Lorie Benning, Lisa P. Jacobson, Robert C. Kaplan, Alan Landay, Russell P. Tracy, Richard Elion

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection

    Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection Tekijä Richard Elion, Calvin Cohen, Joseph Gathe, Peter Shalit, Trevor Hawkins, Hui C. Liu, Anita Mathias, Steven L. Chuck, Brian P. Kearney, David R. Warren

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients

    Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients Tekijä Edwin DeJesus, Daniel Berger, Martin Markowitz, Calvin Cohen, Trevor Hawkins, Peter Ruane, Richard Elion, Charles Farthing, Lijie Zhong, Andrew Cheng, Damian J. McColl, Brian P. Kearney

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection

    Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil... Tekijä Calvin Cohen, Richard Elion, Peter Ruane, David Shamblaw, Edwin DeJesus, Bruce Rashbaum, Steven L. Chuck, Kitty Yale, Hui C. Liu, David R. Warren, S. Ramanathan, Brian P. Kearney

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies

    Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies Tekijä Mark Nelson, Richard Elion, C Cohen, Anthony Mills, Sally Hodder, Sorana Segal‐Maurer, Mark Bloch, Will Garner, Bill Guyer, Scott Williams, S.K. Chuck, Simon Vanveggel, H. Deckx, Marita Stevens

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV

    Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV Tekijä Sonia Vibhakar Patel, Dushyantha Jayaweera, Keri N. Althoff, Joseph J. Eron, Janna Radtchenko, Anthony Mills, Graeme Moyle, Steven Santiago, Paul E. Sax, Jason Gillman, Karam Mounzer, Richard Elion, Gregory Huhn

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen

    Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen Tekijä Monica Gandhi, Pamela M. Murnane, Peter Bacchetti, Richard Elion, Michael A. Kolber, Stephanie E. Cohen, Howard Horng, Alexander Louie, Karen Kuncze, Catherine A. Koss, Peter L. Anderson, Susan Buchbinder, Albert Liu

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project

    Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project Tekijä Eric C. Tang, Eric Vittinghoff, Peter L. Anderson, Stephanie E. Cohen, Susanne Doblecki‐Lewis, Oliver Bacon, Megan Coleman, Susan Buchbinder, Wairimu Chege, Michael A. Kolber, Richard Elion, Michael G. Shlipak, Albert Liu

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients

    Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients Tekijä Wafaa El‐Sadr, Deborah Donnell, Geetha Beauchamp, H. Irene Hall, Lucia V. Torian, Barry S. Zingman, Garret Lum, Michael Kharfen, Richard Elion, Jason Leider, Fred M. Gordin, Vanessa Elharrar, David Burns, Allison Zerbe, Theresa Gamble, Bernard M. Branson

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    High Interest in Preexposure Prophylaxis Among Men Who Have Sex With Men at Risk for HIV Infection

    High Interest in Preexposure Prophylaxis Among Men Who Have Sex With Men at Risk for HIV Infection Tekijä Stephanie E. Cohen, Eric Vittinghoff, Oliver Bacon, Susanne Doblecki‐Lewis, Brian S. Postle, Daniel J. Feaster, Tim Matheson, Nikole Trainor, Robert Wilder Blue, Yannine Estrada, Megan Coleman, Richard Elion, José G. Castro, Wairimu Chege, Susan Philip, Susan Buchbinder, Michael A. Kolber, Albert Liu

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

    Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1 Tekijä Mark Sulkowski, Joseph J. Eron, David Wyles, Roger Trinh, Jay Lalezari, Chia Wang, Jihad Slim, Laveeza Bhatti, Joseph Gathe, Peter Ruane, Richard Elion, Fritz Bredeek, Robert T. Brennan, Gary Blick, Amit Khatri, Krystal Gibbons, Yiran Hu, Linda Fredrick, Gretja Schnell, Edward Tam, Rakesh Tripathi, Barbara Da Silva‐Tillmann, Barbara McGovern, Andrew Campbell, Thomas Podsadecki

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services

    Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services Tekijä Albert Liu, Stephanie E. Cohen, Eric Vittinghoff, Peter L. Anderson, Susanne Doblecki‐Lewis, Oliver Bacon, Wairimu Chege, Brian S. Postle, Tim Matheson, K. Rivet Amico, Teri Liegler, M. Keith Rawlings, Nikole Trainor, Robert Wilder Blue, Yannine Estrada, Megan Coleman, Gabriel Cardenas, Daniel J. Feaster, Robert M. Grant, Susan Philip, Richard Elion, Susan Buchbinder, Michael A. Kolber

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

    Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-cont... Tekijä Anthony Mills, José Ramón Arribas, Jaime Andrade‐Villanueva, Giovanni DiPerri, Jan van Lunzen, Ellen Koenig, Richard Elion, Matthias Cavassini, Jose Valdez Madruga, Jason Brunetta, David Shamblaw, Edwin DeJesus, Chloe Orkin, David A. Wohl, Indira Brar, Jeffrey L. Stephens, Pierre-Marie Girard, Gregory Huhn, Andrew Plummer, Ya-Pei Liu, Andrew Cheng, Scott McCallister

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC<sup>*</sup>

    Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC<sup>*</sup> Tekijä Amanda D. Castel, Mariah M. Kalmin, Rachel Hart, Heather A. Young, Harlen Hays, Debra Benator, Princy Kumar, Richard Elion, David M. Parenti, Marı́a Elena Ruiz, Angela Wood, Lawrence J. D’Angelo, Natella Rakhmanina, Sohail Rana, Maya Bryant, Annick Hebou, Ricardo Fernández, Stephen Abbott, James A. Peterson, Kathy Wood, Thilakavathy Subramanian, Jeffrey Binkley, Lindsey Powers Happ, Michael Kharfen, Henry Masur, Alan E. Greenberg

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV

    Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV Tekijä Richard Elion, Keri N. Althoff, Jinbing Zhang, Richard D. Moore, Stephen J. Gange, Mari M. Kitahata, Heidi M. Crane, Daniel R. Drozd, James H. Stein, Marina B. Klein, Joseph J. Eron, Michael J. Silverberg, William C. Mathews, Amy C. Justice, Timothy R. Sterling, Charles S. Rabkin, Ángel M. Mayor, Daniel B. Klein, Michael A. Horberg, Ronald J. Bosch, Oghenowede Eyawo, Frank J. Palella

    Julkaistu 2018
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate

    Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate Tekijä Samir K. Gupta, Frank A. Post, José Ramón Arribas, Joseph J. Eron, David A. Wohl, Amanda E. Clarke, Paul E. Sax, Hans‐Jürgen Stellbrink, Stefan Eßer, Anton Pozniak, Daniel Podzamczer, Laura Waters, Chloe Orkin, Jürgen K. Rockstroh, Tatiana Mudrikova, Eugènia Negredo, Richard Elion, Susan Guo, Lijie Zhong, Christoph C Carter, Hal Martin, Diana M. Brainard, Devi SenGupta, Moupali Das

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population

    Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population Tekijä Daniel R. Drozd, Mari M. Kitahata, Keri N. Althoff, Jinbing Zhang, Stephen J. Gange, Sonia Napravnik, Greer Burkholder, William C. Mathews, Michael J. Silverberg, Timothy R. Sterling, Susan R. Heckbert, Matthew J. Budoff, Stephen Van Rompaey, Joseph A. Delaney, Cherise Wong, Weiqun Tong, Frank J. Palella, Richard Elion, Jeffrey N. Martin, John T. Brooks, Lisa P. Jacobson, Joseph J. Eron, Amy C. Justice, Matthew S. Freiberg, Daniel B. Klein, Wendy S. Post, Michael S. Saag, Richard D. Moore, Heidi M. Crane

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study Tekijä Antonella Castagna, Franco Maggiolo, Giovanni Penco, David P. Wright, Anthony Mills, Robert Grossberg, Jean‐Michel Molina, Julie Chas, J. Durant, Santiago Moreno, Manuela Doroana, Mounir Ait‐Khaled, J. Huang, Sherene Min, Ivy Song, Cindy Vavro, Garrett Nichols, Jane Yeo, Judith A. Aberg, Bisher Akil, José Ramón Arribas, J.G. Baril, José Luís Blanco, F. Blanco Quintana, Gary Blick, Vicente Boix Martínez, Olivier Bouchaud, Teresa Branco, U. Fritz Bredeek, MANUEL C. IGLESIAS, Nathan Clumeck, Brian Conway, E DeJesus, Jean L. Delassus, P. de Truchis, Giovanni Di Perri, Massimo Di Pietro, Joan Duggan, Claudine Duvivier, Richard Elion, Joseph Eron, Douglas N. Fish, Joseph Gathe, Richard Haubrich, Heather Henderson, Charles B. Hicks, Laurent Hocqueloux, Sally Hodder, CB Hsiao, Christine Katlama, Michael J. Kozal, Princy Kumar, Sujata N. Lalla-Reddy, Adriano Lazzarin, F Leoncini, Josep M. Llibre, Kamal Mansinho, Philippe Morlat, Karam Mounzer, M. Murphy, C. Newman, Thuy Nguyen, Bacel Nseir, Patrick Philibert, Gilles Pialoux, Isabelle Poizot‐Martin, Moti Ramgopal, Gary Richmond, Dominique Salmon Ceron, Paul E. Sax, A. Scarsella, Michael Sension, Peter Shalit, L Sighinolfi, Louis Sloan, Catherine B. Small, David Stein, K. Tashima, Pablo Tebas, Carlo Torti, Marc Tribble, Didier Troisvallets, Christos Tsoukas, Pompeyo Viciana Fernandez, Derek Ward, Darrell P. Wheeler, Timothy Wilkin, Guy-Patrick Yeni, J. Louise Martin-Carpenter, G. Uhlenbrauck

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: